PSA screening reduces deaths by a fifth
The pro-PSA testing camp has been given a boost with a large randomised study showing it could reduce prostate cancer deaths by about a fifth.
However, the authors acknowledge over-diagnosis is a problem, with roughly 40% of positive tests proving to be false.
They conclude that introducing routine PSA screening now would be premature.
Despite the survival advantage, Professor Ian Olver, CEO of Cancer Council Australia,